Pharming Group To Participate In April Investor Conferences

(MENAFN- GlobeNewsWire - Nasdaq) Leiden, the Netherlands, April 7, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the month of April:

• 25th Annual Needham Virtual Healthcare Conference, April 13, 2026
  Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Monday, April 13 at 08:45 am ET/14:45 CET. A live webcast and replay of the presentation will be available in the“Upcoming Events” and“News” sections of Pharming's website.
• Van Lanschot Kempen Life Sciences Conference 2026, Amsterdam, NL, April 15, 2026

For more information about these conferences, or to schedule a one-on-one meeting with Pharming's management team, please contact Pharming's Investor Relations team at ... or your Needham or Van Lanschot Kempen representative.

About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.

For more information, visit and find us on LinkedIn.

For further public information, contact:
Investor Relations
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: ...

Media Relations
Global: Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E: ...

U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

Attachment

• Pharming attending Investor Conferences April 2026_EN_07APR26

MENAFN07042026004107003653ID1110949963